Literature DB >> 17171143

The importance of magnetic resonance imaging in the evaluation of vertigo and imbalance.

S J Marzo, J P Leonetti.   

Abstract

Vertigo and imbalance are believed to be rare manifestations of skull base neoplasms. Patients with skull base neoplasms can present with vague otolaryngological complaints, including diplopia, facial numbness, facial weakness, hearing loss, tinnitus, hoarseness, headache, and otalgia. Physical examination of these patients can sometimes reveal paralysis or paresis of cranial nerves. Magnetic resonance imaging (MRI) is the gold standard for evaluation of cranial nerve involvement in skull base diseases. Vertigo and imbalance can be manifestations of a neuropathy or lesion within the vestibular system and may be subtle or overlooked findings in patients with skull base diseases. The purpose of this article is to review the clinical manifestations of patients presenting with vertigo and imbalance who were found to have skull base neoplasms. We will also highlight the importance of MRI in diagnosis and management of these patients.

Entities:  

Year:  2000        PMID: 17171143      PMCID: PMC1656871          DOI: 10.1055/s-2000-9334

Source DB:  PubMed          Journal:  Skull Base Surg        ISSN: 1052-1453


  1 in total

1.  Cost-effectiveness of the diagnostic evaluation of vertigo.

Authors:  M G Stewart; A Y Chen; J R Wyatt; S Favrot; S Beinart; N J Coker; H A Jenkins
Journal:  Laryngoscope       Date:  1999-04       Impact factor: 3.325

  1 in total
  2 in total

1.  Clinical assessment of dizzy patients: the necessity and role of diagnostic tests.

Authors:  Mahsa Bakhit; Alireza Heidarian; Sara Ehsani; Maryam Delphi; Seyed Mahmoud Latifi
Journal:  Glob J Health Sci       Date:  2014-03-24

2.  Value of Serum Adiponectin Combined with ABCD2 in Predicting Cerebral Infarction Among Patients with Acute Isolated Vertigo.

Authors:  Shuxia Qian; Xiaoling Zhang; Yanping Wang
Journal:  Neuropsychiatr Dis Treat       Date:  2022-07-29       Impact factor: 2.989

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.